Spyre Therapeutics Inc (NAS:SYRE)
$ 37.755 -1.535 (-3.91%) Market Cap: 1.52 Bil Enterprise Value: 1.43 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1